Coming Soon

Demuris Limited

Registration Number 06255507

Trading name: Demuris

Demuris is a biotechnology company focused on developing innovative therapies for the treatment of pain and inflammation. They utilize their proprietary platform to design and optimize drug candidates, aiming to create effective solutions for unmet medical needs.

Company Overview

Company Name
Demuris Limited
Registration Number
06255507
Founded
22 May 2007
Age
17 years
Industry Region
North East England
Registered Postcode
SR1 1EA

Online Profile

Special Flags

Public Funding Received

Public Funding for Demuris Limited

2021-01-01
Novel Ansamycin Antibiotics to combat AntiMicrobial Resistance
Collaborative R&D
2019-05-01
Development of novel ansamycin antibiotics for the treatment of multi-drug resistant Mycobacterium tuberculosis
Collaborative R&D
2019-04-01
Natural product antibiotics targeting Gram-negative MDR pathogens
Small Business Research Initiative
2018-03-01
New molecular methods for global activation of cryptic biosynthetic gene clusters
Collaborative R&D
2016-05-01
Integrating omics technologies for natural product antibiotic discovery
Feasibility Studies
2016-04-01
Opening the highway from genome sequencing to antibiotic discovery
Feasibility Studies
2015-07-01
Rapid Genomic Library Generation Feasibility Study
Feasibility Studies
2014-06-01
Synthetic Biology for antibiotic discovery and development
Collaborative R&D
2013-08-01
Use of Synthetic Biology methods to enhance and optimise production of a novel antibiotic
Feasibility Studies
2013-06-01
Natural Product Antibiotics for multi-drug resistant pathogens
Feasibility Studies
2011-07-01
The Development and Commercialisation of Novel Antibiotic Compounds
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.